Improvements and greater familiarity with artificial intelligence methods such as Natural Language Processing will lead to systems of checks and balances that will create trust and fulfill the promise of computer-assisted precision medicine.
As we advance personalized medicine, we find that the ability to capture robust, structured, detailed data—including biomarkers, dosing, duration, histology, and claims information in electronic systems is incredibly powerful to further insights in oncology. Even more powerful is pairing these electronic health records with technologies to unleash the power of the unstructured data as well. This is the natural synergy of technology taking its rightful place in the clinic. Having these data available to us is clearly supporting breakthroughs in many types of cancers.
Managing these growing volumes of data to find patterns and outcomes will be key. Improvements and greater familiarity with data technologies will lead to systems of checks and balances that will create trust and fulfill the promise of computer-assisted precision medicine. However, for each advance in technology we will still need experienced physicians to question the algorithms, analyses, and underlying assumptions. Physician collaboration with data scientists will build the understanding and fine-tune the research. This will be the unstoppable combination that will transform caution into confidence!